7-isopropoxy-8-methyl-4-piperazino-2H-2-chromenone | 714961-41-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 7-isopropoxy-8-methyl-4-piperazino-2H-2-chromenone
• 英文别名: 8-Methyl-4-piperazin-1-yl-7-propan-2-yloxychromen-2-one
• CAS: 714961-41-8
• 化学式: C₁₇H₂₂N₂O₃
• 分子量: 302.373
• InChiKey: NBFFWQJCMJPRKY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.47
• 拓扑面积：
  50.8
• 氢给体数：
  1
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  (2S)-N-[4-(5-bromopentyloxy)-5-methoxy-2-nitrobenzoyl]pyrrolidine-2-carboxaldehyde diethyl thioacetal 、 7-isopropoxy-8-methyl-4-piperazino-2H-2-chromenone 在 potassium carbonate 作用下， 以 乙腈 为溶剂， 反应 48.0h， 生成 (2S)-N-{4-[5-[4-[4-(7-isopropoxy-8-methyl-2-oxo-2H-2-chromenyl)piperazino]pentyl]oxy]-5-methoxy-2-nitrobenzoyl}pyrrolidine-2-carboxaldehyde diethylthioacetal
  参考文献：
  名称：

  Novel pyrrolo[2,1-C] [1,4] benzodiazepine compounds and processes for the preparation thereof

  摘要：

  本发明提供了新型吡咯并[2,1-c][1,4]苯二氮䓬化合物。本发明还提供了一种制备新型吡咯并[2,1-c][1,4]苯二氮䓬化合物的方法。这些新型吡咯并[2,1-c][1,4]苯二氮䓬化合物可用作抗肿瘤剂。还提供了一种制备7-甲氧基-8-{n-[4-(2-氧代-2H-4-香豆素基)哌嗪基]烷基}-氧基-(11aS)-1,2,3,11a-5H-吡咯并[2,1-c][1,4]苯二氮䓬-5-酮和7-甲氧基-8-{n-[4-(7-烷氧基-8-甲基-2-氧代-2H-4-香豆素基)哌嗪基]烷基}-氧基-(11aS)-1,2,3,11a-5H-吡咯并[2,1-c][1,4]苯二氮䓬-5-酮的方法，其中这些化合物具有不同的脂肪链长度变化。

  公开号：

  US20070082891A1
• 作为产物：
  描述：

  1-(2-hydroxy-4-isopropoxy-3-methylphenyl)ethanone 在 sodium 作用下， 以 二苯醚 、 xylene 为溶剂， 反应 2.0h， 生成 7-isopropoxy-8-methyl-4-piperazino-2H-2-chromenone
  参考文献：
  名称：

  Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins

  摘要：

  Pursuing our chemical and biological studies in this field, we described the multistep preparation of the new 5-, 6-, or 7-alkoxy and 7-alkoxy-8-methyl substituted 4-(1-piperazinyl)coumarins 5d-v, as well as the in vitro evaluation of their inhibitory activity on human platelet aggregation induced in platelet-rich plasma by ADP, collagen or the Ca2+ ionophore A23187. Compounds 5h-j,p,r-u showed notably high activity towards all the platelet aggregation inducers used, and the most active one, 8-methyl-4-(1-piperazinyl)-7-(3-pyridylmethoxy)coumarin (5t), proved to be a potent in vitro antiplatelet agent. (C) 2004 Elsevier SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2003.12.010

文献信息

• WO2007/54954
  申请人：——

  公开号：——

  公开（公告）日：——
• US7312210B2
  申请人：——

  公开号：US7312210B2

  公开（公告）日：2007-12-25
• [EN] A NOVEL PYRROLO[2,1-C][1,4]BENZODIAZEPINE HYBRID AND A PROCESS FOR THE PREPARATION THEREOF<br/>[FR] NOUVEL HYBRIDE DE PYRROLO[2,1-c][1,4]BENZODIAZÉPINE ET PROCÉDÉ POUR LA PRÉPARATION DE CELUI-CI
  申请人：COUNCIL SCIENT IND RES

  公开号：WO2007054954A1

  公开（公告）日：2007-05-18

  [EN] The present invention provides novel pyrrolo [2,1-c][1,4]benzodiazepine hybrid. This invention also provides a process for the preparation of novel pyrrolo[2,1-c][1,4] benzodiazepine hybrid. These novel pyrrolo [2,1-c][1,4]benzodiazepine hybrid are useful as antitumour agents. More particularly, it provides a process for the preparation of 7-methoxy-8-n-[4-(2-oxo-2H-4-chromenyl)piperazino]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one and 7-methoxy-8-n-[4-(7-alkoxy-8-methyl-2-oxo-2H-4-chromenyl)piperazino]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]. benzodiazepine-5-one with aliphatic chain length variations for these compounds.
  [FR] La présente invention concerne un nouvel hybride de pyrrolo[2,1-c][1,4]benzodiazépine. Cette invention concerne également un procédé pour la préparation d'un nouvel hybride de pyrrolo[2,1-c][1,4]benzodiazépine. Ces nouveaux hybrides de pyrrolo[2,1-c][1,4]benzodiazépine sont utiles en tant qu'agents antitumoraux. Plus particulièrement, l'invention concerne un procédé pour la préparation de 7-méthoxy-8-n-[4-(2-oxo-2H-4-chroményl)pipérazino]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazépin-5-one et de 7-méthoxy-8-n-[4-(7-alcoxy-8-méthyl-2-oxo-2H-4-chroményl)pipérazino]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazépine-5-one avec des variations de la longueur de la chaîne aliphatique pour ces composés.
• Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins
  作者：Mario Di Braccio、Giancarlo Grossi、Giorgio Roma、Maria Grazia Signorello、Giuliana Leoncini

  DOI：10.1016/j.ejmech.2003.12.010

  日期：2004.5

  Pursuing our chemical and biological studies in this field, we described the multistep preparation of the new 5-, 6-, or 7-alkoxy and 7-alkoxy-8-methyl substituted 4-(1-piperazinyl)coumarins 5d-v, as well as the in vitro evaluation of their inhibitory activity on human platelet aggregation induced in platelet-rich plasma by ADP, collagen or the Ca2+ ionophore A23187. Compounds 5h-j,p,r-u showed notably high activity towards all the platelet aggregation inducers used, and the most active one, 8-methyl-4-(1-piperazinyl)-7-(3-pyridylmethoxy)coumarin (5t), proved to be a potent in vitro antiplatelet agent. (C) 2004 Elsevier SAS. All rights reserved.
• Novel pyrrolo[2,1-C] [1,4] benzodiazepine compounds and processes for the preparation thereof
  申请人：Kamal Ahmed

  公开号：US20070082891A1

  公开（公告）日：2007-04-12

  The present invention provides novel pyrrolo [2,1-c][1,4]benzodiazepine compounds. This invention also provides a process for the preparation of novel pyrrolo[2,1-c][1,4]benzodiazepine compounds. These novel pyrrolo [2,1-c][1,4]benzodiazepine compounds are useful as antitumor agents. It also provides a process for the preparation of 7-methoxy-8-n-[4-(2-oxo-2H-4-chromenyl)piperazino]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]benzodiazepin-5-one and 7-methoxy-8-n-[4-(7-alkoxy-8-methyl-2-oxo-2H-4-chromenyl)piperazino]alkyl}-oxy-(11aS)-1,2,3,11a-5H-pyrrolo[2,1-c][1,4]. benzodiazepine-5-one with aliphatic chain length variations for these compounds.

  本发明提供了新型吡咯并[2,1-c][1,4]苯二氮䓬化合物。本发明还提供了一种制备新型吡咯并[2,1-c][1,4]苯二氮䓬化合物的方法。这些新型吡咯并[2,1-c][1,4]苯二氮䓬化合物可用作抗肿瘤剂。还提供了一种制备7-甲氧基-8-n-[4-(2-氧代-2H-4-香豆素基)哌嗪基]烷基}-氧基-(11aS)-1,2,3,11a-5H-吡咯并[2,1-c][1,4]苯二氮䓬-5-酮和7-甲氧基-8-n-[4-(7-烷氧基-8-甲基-2-氧代-2H-4-香豆素基)哌嗪基]烷基}-氧基-(11aS)-1,2,3,11a-5H-吡咯并[2,1-c][1,4]苯二氮䓬-5-酮的方法，其中这些化合物具有不同的脂肪链长度变化。